These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9379436)

  • 1. Orally active trifluoromethyl ketone inhibitors of human leukocyte elastase.
    Veale CA; Bernstein PR; Bohnert CM; Brown FJ; Bryant C; Damewood JR; Earley R; Feeney SW; Edwards PD; Gomes B; Hulsizer JM; Kosmider BJ; Krell RD; Moore G; Salcedo TW; Shaw A; Silberstein DS; Steelman GB; Stein M; Strimpler A; Thomas RM; Vacek EP; Williams JC; Wolanin DJ; Woolson S
    J Med Chem; 1997 Sep; 40(20):3173-81. PubMed ID: 9379436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones.
    Cregge RJ; Durham SL; Farr RA; Gallion SL; Hare CM; Hoffman RV; Janusz MJ; Kim HO; Koehl JR; Mehdi S; Metz WA; Peet NP; Pelton JT; Schreuder HA; Sunder S; Tardif C
    J Med Chem; 1998 Jul; 41(14):2461-80. PubMed ID: 9651152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
    Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evaluation of selected, orally active, peptidyl inhibitors of human neutrophil elastase.
    Janusz MJ; Durham SL; Hare CM; Geary JL; Mandagere AK; Poole JC; Thompson TN; Xu D; Anagelastro MR; Burkhart JP
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1233-8. PubMed ID: 8531086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones.
    Skiles JW; Fuchs V; Miao C; Sorcek R; Grozinger KG; Mauldin SC; Vitous J; Mui PW; Jacober S; Chow G
    J Med Chem; 1992 Feb; 35(4):641-62. PubMed ID: 1542092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of trifluoromethyl ketone-based elastase inhibitors on neutrophil function in vitro.
    Huang YI; Surichamorn W; Cao GL; Meng M; Pou S; Rosen GM; Salcedo TW; Strimpler A; Veale C; Bernstein PR; Bonuccelli CM
    J Leukoc Biol; 1998 Sep; 64(3):322-30. PubMed ID: 9738658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of human neutrophil elastase.
    Edwards PD; Andisik DW; Bryant CA; Ewing B; Gomes B; Lewis JJ; Rakiewicz D; Steelman G; Strimpler A; Trainor DA; Tuthill PA; Mauger RC; Veale CA; Wildonger RA; Williams JC; Wolanin DJ; Zottola M
    J Med Chem; 1997 Jun; 40(12):1876-85. PubMed ID: 9191965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and in vitro evaluation of inhibitors of human leukocyte elastase based on a functionalized cyclic sulfamide scaffold.
    Zhong J; Gan X; Alliston KR; Groutas WC
    Bioorg Med Chem; 2004 Feb; 12(3):589-93. PubMed ID: 14738969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and mechanism of action of novel thiocarbamate inhibitors of human leukocyte elastase.
    Li-Pan ZS; Joshi HV; Digenis GA
    J Enzyme Inhib; 2000; 15(1):63-77. PubMed ID: 10850955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptidic inhibitors of human leukocyte elastase. 5. Design, synthesis, and X-ray crystallography of a series of orally active 5-aminopyrimidin-6-one-containing trifluoromethyl ketones.
    Veale CA; Bernstein PR; Bryant C; Ceccarelli C; Damewood JR; Earley R; Feeney SW; Gomes B; Kosmider BJ; Steelman GB
    J Med Chem; 1995 Jan; 38(1):98-108. PubMed ID: 7837246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of elastase by a synthetic cotton-bound serine protease inhibitor: in vitro kinetics and inhibitor release.
    Edwards JV; Bopp AF; Batiste S; Ullah AJ; Cohen IK; Diegelmann RF; Montante SJ
    Wound Repair Regen; 1999; 7(2):106-18. PubMed ID: 10231512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poststatin, a new inhibitor of prolyl endopeptidase. V. Endopeptidase inhibitory activity of poststatin analogues.
    Tsuda M; Muraoka Y; Nagai M; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1996 Sep; 49(9):890-9. PubMed ID: 8931723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the development of elastase inhibitors.
    Donarska B; Z Łączkowski K
    Future Med Chem; 2020 Oct; 12(20):1809-1813. PubMed ID: 33016117
    [No Abstract]   [Full Text] [Related]  

  • 14. Peptides containing acylated C-terminal gem diamines: novel irreversible inactivators of the cysteine and serine proteinases.
    Gilmore BF; Lynas JF; Harriott P; Healy A; Walker B
    Chem Biol Drug Des; 2006 May; 67(5):364-9. PubMed ID: 16784461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpeptidic inhibitors of human leukocyte elastase. 6. Design of a potent, intratracheally active, pyridone-based trifluoromethyl ketone.
    Bernstein PR; Gomes BC; Kosmider BJ; Vacek EP; Williams JC
    J Med Chem; 1995 Jan; 38(1):212-5. PubMed ID: 7837235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acyl and N-sulfonyloxazolidine-2,4-diones are pseudo-irreversible inhibitors of serine proteases.
    Santana AB; Lucas SD; Gonçalves LM; Correia HF; Cardote TA; Guedes RC; Iley J; Moreira R
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3993-7. PubMed ID: 22595175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoxazol-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors.
    Vergelli C; Schepetkin IA; Crocetti L; Iacovone A; Giovannoni MP; Guerrini G; Khlebnikov AI; Ciattini S; Ciciani G; Quinn MT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):821-831. PubMed ID: 28612630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of peptide-based carboxylic acid-containing transition-state inhibitors of human neutrophil elastase.
    Sato F; Inoue Y; Omodani T; Imano K; Okazaki H; Takemura T; Komiya M
    Bioorg Med Chem Lett; 2002 Feb; 12(4):551-5. PubMed ID: 11844670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proline-based macrocyclic inhibitors of the hepatitis C virus: stereoselective synthesis and biological activity.
    Chen KX; Njoroge FG; Vibulbhan B; Prongay A; Pichardo J; Madison V; Buevich A; Chan TM
    Angew Chem Int Ed Engl; 2005 Nov; 44(43):7024-8. PubMed ID: 16211639
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease.
    Perni RB; Almquist SJ; Byrn RA; Chandorkar G; Chaturvedi PR; Courtney LF; Decker CJ; Dinehart K; Gates CA; Harbeson SL; Heiser A; Kalkeri G; Kolaczkowski E; Lin K; Luong YP; Rao BG; Taylor WP; Thomson JA; Tung RD; Wei Y; Kwong AD; Lin C
    Antimicrob Agents Chemother; 2006 Mar; 50(3):899-909. PubMed ID: 16495249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.